Overview
DYAI market data
Price History
DYAI price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for DYAI. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
8-K filing — DYADIC INTERNATIONAL INC (DYAI)SEC EDGAR · Jul 24, 2026, 12:00 PM
Dyadic International Regains Nasdaq ComplianceBenzinga · Jul 24, 2026, 11:30 AM
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme ProgramGlobenewswire Inc · Jul 16, 2026, 12:30 PM
Dyadic Announces Japan Patent Office Allowance Of Claims Covering Its Proprietary Thermothelomyces Heterothallica Recombinant Protein Expression TechnologyBenzinga · Jun 29, 2026, 11:30 AM
Dyadic Highlights Increasing Interest In Proprietary C1 Protein Production Platform As Global Infectious Disease Preparedness Efforts Intensify In Response To Ongoing Bundibugyo Ebola Virus OutbreakBenzinga · Jun 15, 2026, 11:40 AM
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response EffortsBenzinga · Jun 5, 2026, 6:30 PM
Dyadic's Applied Biosolutions Unit Collaborates With Scripps Research To Evaluate Monoclonal Antibody And Vaccine Candidates Targeting Hantaviruses, Including Andes VirusBenzinga · May 28, 2026, 11:35 AM
Skyline Corporate Communications Group, LLC Announces Dyadic Applied BioSolutions to Deliver a Live Presentation at the Skyline Signature Series™ on Wednesday, May 27 at 12:00 PM ETGlobenewswire Inc · May 21, 2026, 8:15 PM
Transcript: Dyadic International Q1 2026 Earnings Conference CallBenzinga · May 13, 2026, 9:54 PM
Dyadic International Q1 EPS $(0.05) Misses $(0.04) Estimate, Sales $1.111M Beat $900.000K EstimateBenzinga · May 13, 2026, 8:12 PM